Tyrosine-modified polyethylenimine polymers as a promising vectors for siRNA delivery in synergistic cancer immunotherapy.
2020/37/N/NZ5/02359
Keywords
Descriptors
- NZ5_007: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska
Voivodeship: łódzkie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 19 – announced on 2020-03-16
- Amount awarded
- 139 800 PLN
- Project start date
- 2021-02-01
- Project end date
- 2024-07-31
- Project duration
- 42 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Articles in post-conference publications (1)
-
The efficacy of vasohibin 2 gene expression knockdown and biological relevance in pancreatic cancer cells and tumor associated macrophages
- Authors:
- M. Kubczak S. Michlewska M. Karimov A. Ewe A. Aigner M. Bryszewska M. Ionov
- Conference:
- Immuno-Oncology and Technology (year: 2022, volume: ESMO Immuno-Oncology Annual Congress, pages: 12), Publisher: ESMO
- Date:
- conference 07-09.12.2022
- Status:
- Published
- DOI:
- 10.1016/j.iotech.2022.100343 – link to the publication